首页 | 官方网站   微博 | 高级检索  
     

ICAM-1在肿瘤中的研究进展
引用本文:庄敏敏,张云艳.ICAM-1在肿瘤中的研究进展[J].实用肿瘤学杂志,2018,32(1):82-86.
作者姓名:庄敏敏  张云艳
作者单位:哈尔滨医科大学附属肿瘤医院(哈尔滨 150081)
摘    要:细胞间黏附分子(Intercellular adhesion molecule-1,ICAM-1)又称CD54,是免疫球蛋白超家族的一种跨膜糖蛋白,参与肿瘤细胞免疫调节、血管生成、侵袭和远处转移。国内外诸多研究证明ICAM-1在多种恶性肿瘤中异常高表达,促进了肿瘤的发生、发展并影响其预后,同时对预测个别肿瘤放化疗敏感性有一定的作用。因此ICAM-1可能为恶性肿瘤的诊断和治疗提供参考依据。本文就近年来ICAM-1在恶性肿瘤中的研究做一综述。

关 键 词:ICAM-1  肿瘤  进展  预后  
收稿时间:2017-07-30

Research progress of intercellular adhesion molecule-1 in tumor
ZHUANG Minmin,ZHANG Yunyan.Research progress of intercellular adhesion molecule-1 in tumor[J].Journal of Practical Oncology,2018,32(1):82-86.
Authors:ZHUANG Minmin  ZHANG Yunyan
Affiliation:Harbin Medical University Cancer Hospital,Harbin 150081,China
Abstract:Intercellular adhesion molecule(ICAM-1),also known as CD54,is a transmembrane glycoprotein of the immunoglobulin superfamily and involved in tumor cell immune regulation,angiogenesis,invasion and distant metastasis.Many studies from domestic and abroad have proved that ICAM-1 is highly expressed in a variety of malignant tumors,which promotes the occurrence,development and prognosis of tumor.ICAM-1 also plays an important role in predicting the chemosensitivity of individual tumors.Therefore,ICAM-1 may provide a reference for the diagnosis and treatment of malignant tumors.This article summarizes effects of ICAM-1 on malignant tumors in recent years.
Keywords:ICAM-1  Tumor  Progress  Prognosis  
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号